Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunization
Research from Zhejiang University broadens understanding of immunization
May 21st, 2008
"Mycobacterium bovis Bacillus Calmette-Guerin (BCG) vaccination has been shown to inhibit allergic airway inflammation in animal models, associated with the regulation of allergen-specific T-cell immunity. However, little is known about whether neonatal BCG treatment could inhibit allergic inflammation by regulating allergen-specific T-cell response in aged mice," investigators in Hangzhou, People's Republic of China report. "This study was aimed to investigate the impact of neonatal BCG treatment on allergic asthma and possible mechanism(s) underlying the action of BCG in different ages of mice. C57BL/6 neonates were vaccinated with BCG on days 1, 7 and 14, sensitized...
Source: Vaccine Weekly (2008-05-21)
|
